Skip to main content

Advertisement

SpringerLink
Log in

Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children

  • Pediatric Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

To evaluate the effect of terlipressin on oxygenation, PaO2/FIO2, heart rate, mean arterial pressure, and mortality in children with septic shock refractory to high doses of dopamine/dobutamine and adrenaline.

Design and setting

A randomized, nonblind study in the pediatric intensive care unit of a university hospital.

Patients and measurements

We studied 58 children with septic shock and refractory hypotension despite fluid loading and high doses of catecholamines, randomly enrolled to terlipressin (TP, n = 30) or control (n = 28). TP was administered as intravenous bolus doses of 20 μg/kg every 6 h for a maximum of 96 h. Hemodynamic changes, PaO2/FIO2 rates, length of stay, and mortality rate in PICU were recorded prospectively.

Results

Mean arterial pressure and PaO2/FIO2 significantly increased, and heart rate significantly decreased 30 min after each TP treatment, but mortality did not differ from control (67.3% vs. 71.4%). Mean stay in the PICU was shorter in the TP group (13.4 ± 7.9 vs. 20.2 ± 9.7 days and was longer among nonsurvivors of the TP group vs. control (10.4 ± 6.9 vs. 6.2 ± 3.4 days). Blood urea nitrogen, creatinine, AST, ALT, and urine output of patients in the TP group did not change after terlipressin.

Conclusions

Although terlipressin infusion had no effect on mortality, it significantly increases mean arterial pressure, PaO2/FIO2, and survival time in nonsurvivors. Terlipressin seems to cause no adverse effect but warrants further evaluation as a rescue therapy in refractory septic shock.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC (2003) The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 167:695–701

    Article  PubMed  Google Scholar 

  2. Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 45:588–595

    Article  Google Scholar 

  3. Meyer J, Booke M, Waurick R, Prien T, van Aken H (1996) Nitric oxide synthase inhibition restores vasopressor effects of norepinephrine in ovine hyperdynamic sepsis. Anesth Analg 83:1009–1013

    Article  PubMed  CAS  Google Scholar 

  4. Holmes CL, Patel BM, Russell JA (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120:989–999

    Article  PubMed  CAS  Google Scholar 

  5. Landry DW, Oliver JA (1992) The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J Clin Invest 89:2071–2074

    Article  PubMed  CAS  Google Scholar 

  6. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent J-L, Levy MM (2004) Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–870

    Article  PubMed  Google Scholar 

  7. Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31:946–955

    Article  PubMed  Google Scholar 

  8. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, Totaro R, Vincent J-L, Zanotti-Cavazzoni S (2004) Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32:1928–1948

    Article  PubMed  Google Scholar 

  9. Martin C, Papazian L, Perrin G, Saux P, Gouin F (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 103:1826–1831

    Article  PubMed  CAS  Google Scholar 

  10. Desjars P, Pinaud M, Potel G, Tasseau F, Touze MD (1987) A reappraisal of norepinehrine therapy in human septic shock. Crit Care Med 15:134–137

    Article  PubMed  CAS  Google Scholar 

  11. Reinhart K, Saka SG, Meier-Hellman A (2000) Haemodynamic management of a patient with septic shock. Eur J Anaeasthesiol 17:6–17

    Article  CAS  Google Scholar 

  12. Schreuder WO, Schneider AJ, Groeneveld AB, Thijs LG (1989) Effect of dopamine versus norepinephrine on hemodynamic in septic shock: emphasis on right ventricular performance. Chest 95:1282–1288

    Article  PubMed  CAS  Google Scholar 

  13. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA (1997) Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25:1279–1282

    Article  PubMed  CAS  Google Scholar 

  14. Hadengue A, Gadano A, Moreau R, Giostra E, Durand F, Valla D, Erlinger S, Lebrec D (1998) Beneficial effects of 2 day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 29:565–570

    Article  PubMed  CAS  Google Scholar 

  15. Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96:576–582

    Article  PubMed  CAS  Google Scholar 

  16. O'Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine resistant septic shock. Lancet 359:1209–1210

    Article  PubMed  Google Scholar 

  17. Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, Gonzalez-Alanso N, Martinon-Sanchez JM (2004) Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 30:477–480

    Article  PubMed  Google Scholar 

  18. Matok I, Leibovitch L, Vardi A, Adam M, Rubinshtein M, Barzilay Z, Paret G (2004) Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 5:116–118

    Article  PubMed  Google Scholar 

  19. Peters M, Booth RA, Petros AJ (2004) Terlipressin bolus induces systemic vasoconstriction in septic shock. Pediatr Crit Care Med 5:112–115

    Article  PubMed  Google Scholar 

  20. Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, Cortese G, Coluzzi F, Vernaglione E, Pelaia P, Pietropaoli P (2004) Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 30:597–604

    Article  PubMed  Google Scholar 

  21. Leone M, Albanese J, Delmas A, Chaabane W, Garnier F, Martin C (2004) Terlipressin in catecholamine-resistant septic shock patients. Shock 22:314–319

    Article  PubMed  CAS  Google Scholar 

  22. Matok I, Vard A, Efrati O, Rubinshtein M, Vishne T, Leibovitch L, Adam M, Barzilay Z, Paret G (2005) Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock 23:305–310

    Article  PubMed  CAS  Google Scholar 

  23. Rodriguez-Nunez A, Lopez-Herce J, Gil-Anton J, Hernandez A, Rey C, RETSPED Working Group of the Spain Society of Pediatric Intensive Care (2006) Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit Care 10:1–8

    Google Scholar 

  24. Siegfried BH, Henderson TO (2002) Cardiology. In: Gunn VL, Nechyba C (eds) The Harriet Lane Handbook, 16th edn. Elsevier Science, Philadelphia, pp 123–168

    Google Scholar 

  25. Greenfield MM (2002) Pulmonology. In: Gunn VL, Nechyba C (eds) The Harriet Lane Handbook, 16th edn. Elsevier Science, Philadelphia, pp 513–527

    Google Scholar 

  26. Hayden WR (1994) Sepsis terminology in pediatrics. J Pediatr 124:657–658

    PubMed  CAS  Google Scholar 

  27. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 19:973–976

    Google Scholar 

  28. Abboud FM, Floras JS, Aylward PE, Guo GB, Gupta BN, Schmid PG (1990) Role of vasopressin in cardiovascular and blood pressure regulation. Blood Vessels 27:106–115

    PubMed  CAS  Google Scholar 

  29. Sharshar T, Blanchard A, Paillard M, Paphael JC, Gajdos P, Annane D (2003) Circulating vasopressin levels in septic shock. Crit Care Med 31:1752–1758

    Article  PubMed  CAS  Google Scholar 

  30. Delmas A, Leone M, Rousseau S, Albanese J, Martin C (2005) Clinical review: vasopressin and terlipressin in septic shock patients. Crit Care 9:212–222

    Article  PubMed  Google Scholar 

  31. Malay MB, Ashton RC Jr, Landry DW, Townsend RN (1999) Low dose of vasopressin in the treatment of vasodilatory septic shock. J Trauma 47:699–703

    PubMed  CAS  Google Scholar 

  32. Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR (2003) Arginine vasopressin in advanced vasodilatory shock. A prospective, randomized, controlled study. Circulation 107:2313–2319

    Article  PubMed  CAS  Google Scholar 

  33. Albanase J, Leone M, Delmas A, Martin C (2005) Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 33:1897–1902

    Article  Google Scholar 

  34. Undesser KP, Hasser EM, Haywood JR, Johnson AK, Bishop VS (1985) Interactions of vasopressin with the postrema in arterial baroreflex function in conscious rabbits. Circ Res 56:410–417

    PubMed  CAS  Google Scholar 

  35. Evora PR, Pearswon PJ, Schaff HV (1993) Arginine vasopressin induces endothelium-dependent vasodilation of pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest 103:1241–1245

    Article  PubMed  CAS  Google Scholar 

  36. Mutlu GM, Factor P (2004) Role of vasopressin in the management of septic shock. Intensive Care Med 30:1276–1291

    PubMed  Google Scholar 

  37. Edwards RM, Trizna W, Kinter LB (1989) Renal effects of vasopressin and vasopressin antagonists. Am J Physiol 256:F274–278

    PubMed  CAS  Google Scholar 

  38. Ceneviva G, Paschall AJ, Maffei F, Carcillo JA (1998) Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 102:e19

    Article  PubMed  CAS  Google Scholar 

  39. Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M (1996) Epidemiology of sepsis and multiorgan dysfunction syndrome in children. Chest 109:1033–1037

    Article  PubMed  CAS  Google Scholar 

  40. Goh A, Chan PWK, Lum LCS (1999) Sepsis, severe sepsis and septic shock in paediatric multiorgan dysfunction syndrome. J Paediatr Child Health 35:488–492

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Pediatrics, Division of Intensive Care Unit, Çukurova University, 01330, Balcali, Adana, Turkey

    Dincer Yildizdas

  2. Faculty of Medicine, Department of Pediatrics, Division of Neonatology, Çukurova University, 01330, Adana, Turkey

    Hacer Yapicioglu

  3. Faculty of Medicine, Department of Pediatrics, Division of Infectious Disease, Çukurova University, 01330, Adana, Turkey

    Umit Celik & Emre Alhan

  4. Faculty of Medicine, Department of Biostatistics, Çukurova University, 01330, Adana, Turkey

    Yasar Sertdemir

Authors
  1. Dincer Yildizdas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hacer Yapicioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Umit Celik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasar Sertdemir
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emre Alhan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dincer Yildizdas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yildizdas, D., Yapicioglu, H., Celik, U. et al. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med 34, 511–517 (2008). https://doi.org/10.1007/s00134-007-0971-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-007-0971-x

Keywords

Search

Navigation